Sun et al. [21] observed upregulated levels of high-sensitivity C-reactive protein (hsCRP), TNF-α, IL-1β, IL-6, IFN-c-inducible protein 10 (IP-10), and RANTES in type 2 diabetes mellitus patients with bone fracture. This evidence concerns the gene CXCL10 and type 2 diabetes mellitus.